The structures of cervinomycins Ax (1) and A2 (2), a potent anti-anaerobic and antimycoplasmal antibiotic were investigated by means of recent NMR techniques of 0-methyl ether (3) and C,O-dimethyl ether (4) obtained by methylation of 2 with CH3I in the presence ofAg2O.The antibiotic 2 posesses a polycyclic structure involving a xanthone skeleton. The structure of 1 was confirmed to be a hydroquinone of 2 from the evidences that oxidation of 1 with Ag2Oand acetylation of 1 with (CH3CO)2Oin pyridine afforded quantitatively 2 and triacetylcervinomycin Ax (7), respectively.
ponents, Ax (1), mp (dec) >240°C, C29H23NO9 and A2 (2) , mp (dec) >290°C, C29H21NO9 which are barely soluble in most solvents. Both components and their acyl derivatives afforded a monocrystal in appropriate solvents, however the X-ray crystallographic analyses were unsuccessful because of extreme instability of the crystals on exposing to air. Therefore, NMRspectroscopic analysis was carried out for cervinomycin methyl derivatives. In this paper we wish to report the structure elucidation of cervinomycin by means of NMRspectroscopy.
Methylation of 2 with CH3I in the presence of Ag2Oin CHC13-MeOHafforded two methyl cyclic skeleton containing quinone nucleus. As shown in Fig. 2 , the C-H shift correlated 2D NMR spectrum (in CDC13) of 3 indicated the presence of a tertiary methyl (8 1.43), three methylenes (C-, iVand 0-methylenes), three methoxyls (8 4.01, 4.03 and 4.ll) in which the latter has been introduced by 0-methylation of 2. In the low field region, AB type protons (8 7.93 18 the former couples with C-7 (3/CH=4.0 Hz), C-ll (3/CH=6.9 Hz) and C-25 (3/CH=4.9 Hz) and the latter, with C-8 (3/CH=7.7 Hz), C-12 (3/OH=3.6 Hz) and C-24 (3/CH=5.3 Hz). The location of a phenolic hydroxyl group on the C-26 of 2 (or 1) was assigned from the /3-shift of C-25 (J 3.6 ppm) and C-27 {A ll.2 ppm) by methylation of the hydroxyl. These NMRevidences deduced the existence of a partial structure II consisting of conjugated five rings including a 1,4-benzoquinone moiety for 3. The validity of structure II was also confirmed from the observation of the nuclear Overhauser effect (NOE) of H-7 in ring C with H-5 in ring B and H-9 in ring D. There are two possibilities (A) and (B) for the connectivity ofI to II as shown in Fig. 3 . In general, the chemical shift value of a quinone carbonyl carbon (or hydroquinone carbonyl) neighbor to the carbonyl of f-pyrone system, as indicated in bikaverin,5) a fungal metabolite, appears to be deshieled compared with the value when a quinone carbonyl locates to the ether oxygen of a f-pyrone. The observation of 4/CH=0.7 Hz between H-10 and C-13 (8 153.6) attached to an ether oxygen in addition to the above chemical shift values (C-12; 3 178.2 and C-23; 3 183.2) validated the connectivity (A). The structures of 2 and 3 were further confirmed from the detailed NMRdata of monoacetylcervinomycin A2 (6), C31H23NO16which was obtained by acetylation of 2 with (CH3CO)2O in pyridine in the presence of Et3N. Thus, a novel polycyclic structure containing a xanthone skeleton was assigned for 2.
The structure of the second methylation product 4 was assigned as the C-7 methylation product from a comparison with the chemical shift values of 3 and the observation of 3/0H of the methyl proton (3 2.47) at C-7 with C-6 (3 135.6) and C-8 (3 138.9). It seems to be quite rare that the C-methylation occurs at /^ra-position of a doubly^-substituted phenol derivative with CH3I in the presence of Ag2O. The formation of 4 seems to proceed the mechanism through C-methylation and then O- Compound 2 was measured in CDC13 -CD3ODand 3, 4, 6 in CDC13.
* ppm. Table 1 .
Three xanthone antibiotics, lysolipin I, a glycopeptide synthesis inhibitor,6>r) albofungin (BA-180265, kanchanomycin) and chloroalbofungin, a DNAand RNAsynthesis inhibitor8»9) have been reported as cervinomycin related antibiotics. The structures of lysolipin I and albofungin have been established by X-ray analysis and chemical degradation, respectively, as shown in Fig. 5 . Recently, LL-D42067a: and /3 were reported as an antibacterial and anti-protozoal antibiotic in which the structure and stereochemistry were assigned by X-ray analysis.10) The location of the carbonyl group in the xanthone ring of cervinomycin is identical with that of lysolipin I and LL-D42067. However, it is a noteworthly that the carbonyl group in albofungin is oppositely located compared with that of other three antibiotics. Weare nowinvestigating the biosynthetic correlation amongcervinomycin, lysolipin I, and albofungin by feeding experiment using 13C-labeled precursors.
Triacetate 7 showed enhanced anti-anaerobic activity against Clostridium difficile, Peptococcus variabilis and Streptococcus mutans and anti-mycoplasmal activity.n) It is being developed as a medicinal drug because of its high solubility in most solvents and low toxicity in addition to a potent antimicrobial activity.
Exp erimen tal General Methods Melting points were determined with a Yanagimoto MP-S3apparatus and are uncorrected. Optical rotations were measured with a polarimeter Jasco DIP-181. :H and 13C NMRspectra were recorded with TMSas an internal standard in CDC13(or CDC13-CD3OD)with a Varian XL-400. Massspectra were recorded with a JMS-D100mass spectrometer. IR spectra were recorded with Shimadzu UV-210 A infrared spectrometer. Silica gel TLCwas performed on pre-coated TLCplates Silica gel 60 F254 (Merck).
O-Methylcervinomycin A2 (3) and C,O-Dimethylcervmomycin A2 (4) Excess CH3I (2.5 ml) was added to a suspension of 2 (200 mg) in CHC13 (5 ml) and MeOH(2 ml) in the presence of Ag2O(70 mg). The reaction mixture was stirred at 30°C for 72 hours and then filtered. The filtrate was concentrated to dryness. The reaction products were purified on silica gel TLC (0.5 mm) using a solvent system of CHC13 -MeOH-NH4OH Alkaline Degradation Product (5) from 2 A solution of2 (80mg) (or 1) in 0.5 n KOH(3 ml) and dioxane (10ml) was allowed to stand at 100°C for 48 hours. After acidification of the reaction mixture with 1 n HC1, the solution was extracted with EtOAc (20 ml). The extract was concentrated to dryness. The residue was purified on silica gel TLC (0.5 mm) using a solvent system of CHC13 -MeOH-NH4OH ( Monoacetylcervinomycin A2 (6) A suspension of 2 (100 mg) in pyridine (3 ml) and (CH3CO)2O (0.3 ml) in the presence of Et3N as a catalyst was stirred at room temp for 24 hours. The reaction mixture was poured on ice-water (70ml) and then extracted with EtOAc (25 ml). The extract was washed with 1% NaHCO3and then evaporated to dryness. The residue was purified on silica gel TLC (0.5 mm) using a solvent system of CHC13-MeOH-NH4OH(15 : 1 :0.01) to obtain monoacetate 6 as an orange needles. Oxidative Transformation of 1 to 2 A suspension of 1 (50 mg) in CHC13 (4 ml) and MeOH(3.5 ml) in the presence of Ag2O (30 mg) was stirred at 65°C for 24 hours. After nitration of reaction mixture, the solution was evaporated to dryness. The residue was purified on silica gel TLC(0.5 mm)using a solvent system of CHC13-MeOH-NH4OH(15 : 1 :0.01) to afford an orange crystalline powder, which was identified with 2 from the IR, MS, UV and NMRspectral data.
